New Director of Quality
Welcome Bob Brady
Birmingham, Alabama – August, 2006 – Brookwood Pharmaceuticals welcomes Robert J. Brady as the Director of Quality. “We are pleased to welcome Bob to our team,” says Arthur J. Tipton, PhD, CEO and President. “He adds a wealth of experience and is a definite asset for the growing quality group at Brookwood Pharmaceuticals”.
“Working here at Brookwood is my definition of a dream job,” said Bob. “I have always been attracted to smaller, entrepreneurial firms involved in cutting edge technology, producing healthcare products that can have meaningful impact on people's wellness and quality of life. Brookwood has an outstanding staff of high-caliber, well trained scientists who are leaders in their respective fields. Individual employees are empowered and are capable of making a significant impact on the company's success.”
Bob added, “The fact that Brookwood is located in Birmingham, Alabama, the heart of the Deep South, is an added bonus. The city is a fast-rising metropolitan area with a great many cultural and educational opportunities to offer, and it is convenient to many great recreational attractions.”
Robert J. Brady comes to Brookwood Pharmaceuticals with 34-years experience in Quality Assurance and cGMP, cGCP, and cGLP compliance.
With the U.S. Food and Drug Administration, Bob obtained 13-years experience as a field investigator and gained extensive knowledge in drug manufacturing. He was with the FDA when medical devices. He worked in the Philadelphia, Boston and New Jersey District Offices on a variety of pharmaceutical facility inspections. He also has experience in the inspections of biologics, medical devices and bioresearch monitoring activities. Bob is a graduate of Temple University in Philadelphia, PA with a B.A. degree in Anthropology.
Bob held quality management positions of increasing responsibility as a compliance auditor and Manager of Quality Assurance Operations with Boehringer Ingelheim Pharmaceuticals. He was also a Manager and Director of Quality Compliance with Schering-Plough.
Prior to joining Brookwood, Bob worked as an independent consultant to the pharmaceutical industry in the areas of compliance auditing, equipment and facility qualification, clinical manufacturing and training.
Bob has significant experience internationally conducting audits, hosting regulatory inspections, training, working with regulatory officials in Europe and the Middle East, and in helping to prepare data for international regulatory submissions. In September 2006 Bob will be the keynote speaker at the “3rd Annual surviving an FDA Audit Conference” in Baltimore, MD.
Bob has presented at several professional meetings, most recently hosting a Webcast presentation on the current US and EU cGMP requirements for the Regulatory Affairs Professionals Society (RAPS).
“The great work going on here at Brookwood has only scratched the surface of the potential for biodegradable polymers coupled with pharmaceutical or biological products as drug delivery systems, or for medical devices. Hardly a day goes by that I don't learn about a new application under development that has real potential as a significant new medical treatment. When we launch our first commercial product it will be a very exciting and fulfilling event that many here will find personally rewarding. The past year and a half has already seen a lot of success and we are growing a great reputation in the industry,” said Brady.
Contact information:
Lakeshore Biomaterials
756 Tom Martin Drive
Birmingham, AL 35211
phone 205.917.2290
fax 205.917.2291
Or visit our Contact Page.